99
Views
23
CrossRef citations to date
0
Altmetric
Original

Regulatory T cells in peripheral blood of patients with mixed connective tissue disease

, , , , , , & show all
Pages 300-304 | Received 20 May 2005, Accepted 10 Feb 2006, Published online: 12 Jul 2009
 

Abstract

Objective: To determine the percentage and absolute number of CD4+ regulatory T‐cells (Treg) in 48 patients with mixed connective tissue disease (MCTD).

Methods: Data were classified on the basis of the stage of the disease: 17 patients were in the active stage and 31 in the inactive stage. The absolute number of CD4+/intracellular interleukin‐10+ (IL‐10+) and CD4+CD25+high Treg cells was determined by flow cytometry. The percentage of CD4+CD25+high suppressor T‐cells was determined on the basis of Foxp3 expression.

Results: The percentage and the absolute number of CD4+CD25+high Treg cells were lower in patients than in healthy controls (p<0.04), and were further decreased in patients with active MCTD and were lower than in the inactive stage (p<0.01). There was an increase in the percentage and absolute number of CD4+IL‐10+ Treg cells in patients with MCTD compared to the healthy controls (p<0.02). The percentage of CD4+IL‐10+ Treg cells was higher in the active stage of MCTD than in the inactive stage of the disease (p<0.005). However, we did not find any significant difference in the absolute number of CD4+IL‐10+ Treg cells between the patients in the active and inactive stages of MCTD.

Conclusion: Our results suggest that the decrease in the number of CD4+CD25+high Treg cells in an important factor in the immunoregulatory disturbance in patients with MCTD. We suggest that the increase in the number of CD4+IL‐10+ Treg cells is a compensatory mechanism aiming to restore the balance between type 1 and type 2 cytokines in MCTD.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.